Articles by Disease (Optic Neuropathy, Ischemic)

Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced Obesity

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19
Page: 1046-1054
Author(s): Fanqing Meng, Dongliang Li , Bingfeng Song and Liang Li *

Drug Repurposing for Retinoblastoma: Recent Advances

Journal: Current Topics in Medicinal Chemistry
Volume: 19
Page: 1535-1544
Author(s): Kamakshi Dandu, Prathap R. Kallamadi, Suman S. Thakur* and Ch. Mohan Rao*

Mitochondria-Targeted Drugs

Journal: Current Molecular Pharmacology
Volume: 12
Page: 202-214
Author(s): Roman A. Zinovkin* and Andrey A. Zamyatnin*

Proteomic Analysis of Cerebrospinal Fluid: A Search for Biomarkers of Neuropsychiatric Systemic Lupus Erythematosus

Journal: Current Proteomics
Volume: 16
Page: 110-118
Author(s): Johanna Pedroza-Díaz*, Tania Paola Luján Chavarria, Carlos Horacio Muñoz Vahos, Diego Francisco Hernández Ramírez, Elizabeth Olivares-Martínez, Gloria Vásquez, Luis Llorente, Hilda Fragoso-Loyo, Sarah Röthlisberger and Blanca Lucía Ortiz Reyes

Statins and the Brain: More than Lipid Lowering Agents?

Journal: Current Neuropharmacology
Volume: 17
Page: 59-83
Author(s): Anna Fracassi , Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni and Marco Segatto*

Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System

Journal: Current Drug Targets
Volume: 20
Page: 29-50
Author(s): Ana C.N. Oliveira, Joana Fernandes, Anabela Gonçalves, Andreia C. Gomes* and M.E.C.D. Real Oliveira*

Articles by Disease (Optic Neuropathy, Ischemic)

Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced Obesity

Drug Repurposing for Retinoblastoma: Recent Advances

Mitochondria-Targeted Drugs

Proteomic Analysis of Cerebrospinal Fluid: A Search for Biomarkers of Neuropsychiatric Systemic Lupus Erythematosus

Statins and the Brain: More than Lipid Lowering Agents?

Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System

Nerve Growth Factor: Early Studies and Recent Clinical Trials

Novel Therapeutics in Glaucoma Management

Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function

Rational Basis for Nutraceuticals in the Treatment of Glaucoma